| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/21/2008 | US20080044859 Fibroblast Growth Factor Receptor-Like Molecules and Uses Thereof |
| 02/21/2008 | US20080044430 Agent for Stimulating the Production of a Blood Coagulation Factor VIII |
| 02/21/2008 | US20080044425 Polypeptides having phospholipase a2 activity |
| 02/21/2008 | US20080044385 Novel Modified Galectin 8 Proteins and Use Thereof |
| 02/21/2008 | CA2650206A1 Novel crystal of 5-aminolevulinic acid phosphate and process for producing the same |
| 02/20/2008 | EP1889908A1 Anti-cd14 antibody-fused protein |
| 02/20/2008 | EP1889838A1 Thrombopoietin mimetics |
| 02/20/2008 | EP1889835A1 Cyclic amine derivative having substituted alkyl group |
| 02/20/2008 | EP1889635A1 Haemodialysis concentrates |
| 02/20/2008 | EP1888567A1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors |
| 02/20/2008 | EP1888566A1 2-[(isoquinolin-3-carbonyl)amino]-propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis |
| 02/20/2008 | EP1888531A2 (5z)-5-(6-quinoxalinylmethylidene)-2-ý(2,6-dichlorophenyl)amino¨-1,3-thiazol-4(5h)-one |
| 02/20/2008 | EP1888092A1 Medicament made from laminarine or oligolaminarines for treatment of septicemia and septic shock |
| 02/20/2008 | EP1740569B1 Imidazole derivatives used as tafia inhibitors |
| 02/20/2008 | EP1545506B1 Use of angelicin and of its structural analogues for the treatment of thalassemia |
| 02/20/2008 | EP1458389B1 Aqueous solutions of moxaverin for the treatment of erectile dysfunction |
| 02/20/2008 | EP1383747B1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 02/20/2008 | EP1359936B1 Combined use of factor vii polypeptides and factor viii polypeptides |
| 02/20/2008 | EP1225915B1 Use of anti-il-2 polyclonal antibodies for the treatment of insulin-dependent diabetes mellitus and lupus erythematosus |
| 02/20/2008 | EP1064010B1 Peptide compositions and formulations and use of same |
| 02/20/2008 | CN101125205A Polyethylene decorative nevin fibrinolytic enzyme and its preparation method |
| 02/20/2008 | CN101125162A Blood-tonifying medicine preparation and its preparation method |
| 02/20/2008 | CN101125139A Application of procyanidin B2 in preparing medicine for preventing and treating diabetes and vascular complication |
| 02/20/2008 | CN101124992A 'Jinsuoyinkai' health-care sugar and production technology thereof |
| 02/20/2008 | CN100369936C Sulfonated changium root polysaccharides and preparing method and use thereof |
| 02/20/2008 | CN100369917C Himbacine analogues as thrombin receptor antagonists |
| 02/20/2008 | CN100369915C 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity |
| 02/20/2008 | CN100369898C Nicotinamide derivates useful as p38 inhibitors |
| 02/20/2008 | CN100369896C Cyclic amino compounds |
| 02/20/2008 | CN100369629C Compound hemostatic |
| 02/19/2008 | US7332521 Substituted indoles |
| 02/19/2008 | US7332497 Pyrazolopyrimidines as therapeutic agents |
| 02/19/2008 | US7332496 Methods of using sodium channel blockers |
| 02/19/2008 | US7332481 Thrombopoietin mimetics |
| 02/19/2008 | US7332474 Peptides and related compounds having thrombopoietic activity |
| 02/19/2008 | US7332473 derived from a PACAP or VIP peptide; can inhibit tautomerization in a solution; regressive neurodegenerative diseases, erectile dysfunction, and bronchial asthma; inhibited isomerization and high stability during the production and storage |
| 02/19/2008 | US7332301 Insulin-like growth factor binding protein |
| 02/19/2008 | US7332185 Component I selected from alpha acids and beta acids and component II selected from alpha acids, beta acids, essential oils, fats and waxes; specific inhibition of cyclooxygenase-2 with little effect on cyclooxygenase-1 |
| 02/19/2008 | CA2383977C Stably preserving oxygen infusion |
| 02/19/2008 | CA2267668C Method for enhancing the efficiency of gene transfer with stem cell factor polypeptide |
| 02/19/2008 | CA2253287C A process for producing a recombinant polypeptide involving the addition of an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium |
| 02/19/2008 | CA2237023C Improved formulation for administration of steroid compounds |
| 02/19/2008 | CA2173976C Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 02/14/2008 | WO2008018529A1 Novel pyrimidine compound having benzyl(pyridylmethyl)amine structure and pharmaceutical comprising the compound |
| 02/14/2008 | WO2008018427A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| 02/14/2008 | WO2008017670A1 Pyrrolo [3, 2 -d] pyrimidines as dpp-iv inhibitors for the treatment of diabetes mellitus |
| 02/14/2008 | WO2008017650A1 An aminoisoquinoline thrombin inhibitor with improved bioavailability |
| 02/14/2008 | WO2008017586A2 Special carbonyl-bis imino compounds for using as p2y11 receptor agonists in the treatment of immune diseases |
| 02/14/2008 | WO2008017123A1 Methods for modulating apoptosis in platelets |
| 02/14/2008 | WO2008017121A1 Methods for modulating apoptosis in platelets |
| 02/14/2008 | WO2007106893A3 Use of thrombin mutants to inhibit the anticoagulation effect of thrombin inhibitors |
| 02/14/2008 | WO2007018248A9 Pyridone compound |
| 02/14/2008 | US20080039530 treating a mammal for a vascular permeability disorder by administering a vascular endothelial sphingosine-1-phosphate receptor agonist comprising 2-amino-2-[2-(4-octaphenyl)ethyl]propane-1,3 diol, or 2-amino-2-methyl-4-[4-heptoxy-phenyl]butane-1-ol |
| 02/14/2008 | US20080039517 2-chloro-4-{[(3S)-1-methyl-5-oxo-3-pyrrolidinyl][(2-methylphenyl)methyl]amino}benzonitrile; for treatment of endometreosis, uterine fibroids, dysmenorrhea, menorrhagia, pre-term labor, or infertility |
| 02/14/2008 | US20080039500 Cerebral Infarction Suppressant |
| 02/14/2008 | US20080039478 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof |
| 02/14/2008 | US20080039475 Compositions and methods for increasing blood platelet levels in humans |
| 02/14/2008 | US20080039446 Substituted isoindoles and their use |
| 02/14/2008 | US20080039396 Freeze drying an aliquot of an aqueous solution blood factor such as antihemophilic factor or blood-coagulation factor IX in the presence of trehalose stabilizer wherein the aliquot is free of albumin; hemophilia treatment |
| 02/14/2008 | US20080039376 Use of Cyclic Anabaenopeptin-type Peptides for the Treatment of a Condition Wherein Inhibition of Carboxypeptidase U is Beneficial, Novel Anabaenopeptin Derivatives and Intermediates Thereof |
| 02/14/2008 | US20080039373 Pegylated Factor VII Glycoforms |
| 02/14/2008 | US20080039370 Stable Oxidation Resistant Powdered Hemoglobin, Methods of Preparing Same, and Uses Thereof |
| 02/14/2008 | US20080038372 Artificial Physiological Salt Solution and Manufacturing Method for Same |
| 02/14/2008 | US20080038312 Insertable or implantable medical devices suitable for gene therapy regimens |
| 02/14/2008 | US20080038264 Compositions and methods for the treatment of immune related diseases |
| 02/14/2008 | US20080038242 sodium-dependent nucleoside transporter 2 inhibitors; for diseases associated with abnormal plasma uric acid levels such as gout, hyperuricemia, urinary lithiasis, hyperuriciemic nephropathy, and acute uric acid nephropathy |
| 02/14/2008 | US20080038231 Processing procedure for peripheral blood stem cells |
| 02/14/2008 | DE102006037920A1 Spezielle Carbonylbisimino-Verbindungen zur Behandlung von Immunerkrankungen Carbonylbisimino specific compounds for the treatment of immune diseases |
| 02/14/2008 | CA2660197A1 Pyrrolo[3,2-d]pyrimidines as dpp-iv inhibitors for the treatment of diabetes mellitus |
| 02/14/2008 | CA2659598A1 Amino phosphate derivative and s1p receptor modulator having same as an active ingredient |
| 02/14/2008 | CA2659154A1 An aminoisoquinoline thrombin inhibitor with improved bioavailability |
| 02/13/2008 | EP1886691A2 A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug |
| 02/13/2008 | EP1886679A2 Methods for controlling highly unsaturated fatty acid content in various tissues |
| 02/13/2008 | EP1886677A1 Use of an inducing agent for the treatment of blood, viral and cellular disorders |
| 02/13/2008 | EP1885347A2 Composition and method for treating nosebleeds |
| 02/13/2008 | EP1689370B1 METHOD FOR THE PRODUCTION OF A SOLID, ORALLY APPLICABLE PHARMACEUTICAL COMPOSITION COMPRISING 5-Chlor-N ( { (5-2-oxo-3- [4- (3-oxo-4-morpholinyl)-phenyl]-1, 3- oxazolidin-5-yl}-methyl)-2-thiophencarboxamide |
| 02/13/2008 | EP1480973B1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| 02/13/2008 | EP1476752A4 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome |
| 02/13/2008 | EP1404650B1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 02/13/2008 | EP1297843B1 Method of photoreduction of hemoglobin vesicles |
| 02/13/2008 | EP1289507B1 Use of an aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects |
| 02/13/2008 | CN101124231A Clopidogrel base suitable for pharmaceutical formulation and preparation thereof |
| 02/13/2008 | CN101123987A Dialysis preparation |
| 02/13/2008 | CN101123960A Use of staurosporine derivatives for the treatment of multiple myeloma |
| 02/13/2008 | CN101121018A Application of recombination FN polypeptide in preparing medicine for treating severe infectious diseases such as septicemia |
| 02/13/2008 | CN101120995A Method for making traditional Chinese medicine decoction for treating serious edema caused by pulmonary heart disease |
| 02/13/2008 | CN101120978A Thrombus granule and preparing method thereof |
| 02/13/2008 | CN101120928A Vitamin K1 orally disintegrating tablets preparation and preparation method thereof |
| 02/13/2008 | CN101120914A Vitamin C injection and its preparation method |
| 02/13/2008 | CN100368411C 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders |
| 02/13/2008 | CN100368017C Compound bioogic component and pharmaceutical preparation possessing function for accelerating hemoglutination |
| 02/13/2008 | CN100367963C Medicinal composition containing bilobalide B and its preparation process and usage |
| 02/13/2008 | CN100367961C Tirofiban hydrochloride freeze-dried powder injecta and preparing method |
| 02/13/2008 | CN100367953C Quercetin solid liposome nano particle preparation and its preparing method |
| 02/13/2008 | CN100367933C Biodegradeable hemostasis powder |
| 02/12/2008 | US7329782 Compounds for the treatment of metabolic disorders |
| 02/12/2008 | US7329777 Methods for treating heart failure, thromboembolic disorders, and pulmonary fibrosis |
| 02/12/2008 | US7329753 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 02/12/2008 | US7329729 Secreted epithelial colon stromal-1 molecules and uses thereof |
| 02/12/2008 | US7329724 For therapy of hemophilia; liquid at a specific pH range of acidity |